Comparative anti-proliferative effects of potential HER2 inhibitors on a panel of breast cancer cell lines.

CONCLUSION: Our pharmacophore model resulted in a high potent ligand that shows high potency against HER2 positive breast cancer and relatively low toxicity towards the normal human cells.
PMID: 31559601 [PubMed - as supplied by publisher]

Source: Breast Cancer - September 25, 2019 Category: Cancer & Oncology Authors: Zalloum H, AbuThiab T, Hameduh T, AlBayyari S, Zalloum W, Abu-Irmaileh B, Mubarak MS, Zihlif M Tags: Breast Cancer Source Type: research